List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 32 studies with search of: Telaprevir
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Conditions: Hepatitis C;   HIV
Intervention: Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir
2 Completed VX-950-TiDP24-C216: A Safety and Efficacy Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
Condition: Hepatitis C, Chronic
Interventions: Drug: Placebo/ Standard Treatment (ST)/ Telaprevir;   Drug: Telaprevir/Standard Treatment (ST)/Placebo;   Drug: Placebo/ Standard Treatment (ST)
3 Recruiting VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir/standard treatment
4 Completed VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.
Conditions: Hepatitis C;   Kidney Diseases
Intervention: Drug: telaprevir
5 Completed VX-950-TiDP24-C210: A Study to Assess the Activity of Telaprevir on Hepatitis C Virus in Treatment Naive Patients Who Are Chronically Infected With Hepatitis C Genotype 4 Infection
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir
6 Completed A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C
Condition: Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Peg-interferon Alfa-2a
7 Active, not recruiting A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 HCV
Condition: Hepatitis C
Interventions: Biological: Peg-Interferon-alfa-2a;   Drug: telaprevir;   Drug: placebo matching telaprevir;   Drug: Ribavirin
8 Recruiting Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
Condition: Hepatitis C
Intervention: Drug: Telaprevir
9 Completed VX-950-TiDP24-C208: An Open-label Study of Telaprevir Administered Every 12 or Every 8 Hours in Combination With Standard Treatment in Treatment Naive Patients With Chronic Genotype 1 Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir
10 Active, not recruiting A Study Evaluating 24-Week Telaprevir-Based Treatment, or Extended Treatment to 48 Weeks, in Chronic Hepatitis C Patients Who Achieve a Rapid Viral Response
Condition: Hepatitis C
Interventions: Drug: telaprevir;   Drug: ribavirin;   Biological: peginterferon alfa-2a
11 Completed VX-950-TiDP24-C209: A Phase 2a Partially Blinded Clinical Study to Evaluate the Viral Kinetics and Safety of Telaprevir in Patients With Genotype 2 or 3 Infection.
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir
12 Completed VX-950-TiDP24-C135: Drug-drug Interaction Trial Between Telaprevir and Methadone.
Condition: Hepatitis C
Intervention: Drug: telaprevir; methadone
13 Completed A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
Condition: Hepatitis C
Interventions: Drug: telaprevir;   Drug: cyclosporine;   Drug: tacrolimus
14 Completed VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers
Condition: Hepatitis C
Intervention: Drug: Telaprevir; Moxifloxacin; Placebo
15 Completed VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
Condition: Hepatitis C
Intervention: Drug: Telaprevir; Escitalopram
16 Completed VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
Conditions: Hepatitis C;   HCV;   HIV;   AIDS
Intervention: Drug: Efavirenz; Tenofovir disoproxil fumarate; Telaprevir
17 Completed Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
Condition: Hepatitis C
Interventions: Drug: VCH-222;   Drug: telaprevir
18 Recruiting A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: telaprevir;   Drug: VX-222;   Drug: ribavirin;   Biological: peginterferon-alfa-2a
19 Recruiting Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin (fixed dose);   Drug: ribavirin (weight-based dose)
20 Recruiting Virology Follow up Study in Subjects Previously Treated With Telaprevir
Condition: Hepatitis C
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-32)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services